Post-natal cardiomyocytes can generate iPS cells with an enhanced capacity toward cardiomyogenic re-differentation by Rizzi, R et al.
Post-natal cardiomyocytes can generate iPS cells
with an enhanced capacity toward cardiomyogenic
re-differentation
R Rizzi
1,2, E Di Pasquale
2,3, P Portararo
2, R Papait
2,3, P Cattaneo
2,3, MVG Latronico
2, C Altomare
4, L Sala
4, A Zaza
4, E Hirsch
5,
L Naldini
6, G Condorelli*
,7,8 and C Bearzi
1,2
Adult mammalian cells can be reprogrammed to a pluripotent state by forcing the expression of a few embryonic transcription
factors. The resultinginduced pluripotent stem (iPS) cells can differentiate into cellsof allthree germ layers. It is well known that
post-natal cardiomyocytes (CMs) lack the capacity to proliferate. Here, we report that neonatal CMs can be reprogrammed to
generate iPS cells that express embryonic-speciﬁc markers and feature gene-expression proﬁles similar to those of mouse
embryonic stem (mES) cell and cardiac ﬁbroblast (CF)-derived iPS cell populations. CM-derived iPS cells are able to generate
chimeric mice and, moreover, re-differentiate toward CMs more efﬁciently then either CF-derived iPS cells or mES cells.
The increased differentiation capacity is possibly related to CM-derived iPS cells retaining an epigenetic memory of the
phenotype of their founder cell. CM-derived iPS cells may thus lead to new information on differentiation processes underlying
cardiac differentiation and proliferation.
Cell Death and Differentiation (2012) 19, 1162–1174; doi:10.1038/cdd.2011.205; published online 20 January 2012
Cell-based therapies constitute a promising therapeutic
option for many pathologies. Unfortunately, the development
of this approach for improving cardiac function in heart failure
is hindered by the difﬁculty in obtaining a reliable source of
functional cardiomyocytes (CMs). In fact, adult CMs are
characterized by a very low proliferation rate, and this limits
their use for replacement therapy.
1 As a consequence, many
cell types have been tested for their potential as a source of
CMs.
2 These have included mesenchymal and hematopoietic
stem cells, skeletal myoblasts, endothelial progenitors, and
resident cardiac stem cells.
3 However, the use of these cells
as CM progenitors is controversial.
To date, embryonic stem (ES) cells constitute the only
reliable source of functional CMs. ES cells derive from the
blastocystorearlyepiblast;whenculturedinvitro,theymature
intoso-calledembryoidbodies(EBs),teratoma-likestructures
that contain cells able to generate the three embryonic layers
(ectoderm, endoderm, and mesoderm).
4 Human ES cells can
generate functional CMs with neonatal cell characteristics.
5
However, the use of human ES cells is hampered by
difﬁculties in lineage generation from in vitro fertilized cells,
their immunogenicity – which is, nevertheless, lower com-
pared with that of adult cells – and above all by restrictions in
some countries on the generation of new embryonic cell
lines.
6
Induced pluripotent stem (iPS) cells – genetically modiﬁed
cells generated by the integration of embryonic transcription
factor genes (Oct4, Sox2, Klf4, and c-Myc (OSKM)) into the
genome of adult somatic cells – may overcome some of the
above-mentioned difﬁculties related to the use of human ES
cells.
7,8 iPS cells have been derived from various sources,
such as gastric epithelial cells, hepatocytes, embryonic
ﬁbroblasts, adult tail-tip ﬁbroblasts, pancreatic cells,
B lymphocytes, and neural stem cells from mouse, as well
as keratinocytes, skin ﬁbroblasts, and peripheral blood cells
from humans.
9 These cells form germ-line adult chimeras and
possessself-renewalandpluripotencycharacteristicsthatare
similar to ES cells.
In addition to their potential in cell-based therapies, iPS
cells may be used in the future for drug development and
testing in vitro, decreasing the necessity of in vivo toxicology
studies. iPS cells have already been generated from cells of
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10 opening up the
possibility of using patient-speciﬁc iPS cells to generate
study models of disease.
In the present study, we determined the ability of post-natal
CMs and cardiac ﬁbroblasts (CFs) to act as a source of iPS
cells. Our results indicate that the genome of differentiated
cardiac cells can be reset to a pluripotent state. Moreover,
we found a genetic propensity in CM-derived iPS cells to
re-differentiate toward the fate of their founder cell.
Results
Primary culture of CMs and CFs and generation of iPS
cells with OSK factors. In an attempt to generate iPS cells
from CMs, we started by transducing primary CM cultures
with lentiviral vectors expressing four pluripotency factors
(OSKM) along with green ﬂuorescent protein (GFP) as a
tracker. We found that CMs were capable of generating
clones with this procedure. However, the number of clones
produced was signiﬁcantly less than that generated by CFs,
even though the transduction index was high in both cell
types (Supplementary Figure 1). We reasoned that this low
clonogenic efﬁciency could be due to the large expression
cassettes of the OSKM lentiviral vectors used, which contain
genes for an embryonic factor plus the GFP marker, limiting
the efﬁciency of transduction and, consequently, of the
reprogramming process. To overcome this problem, we
decided to transduce cells with vectors harboring bicistronic
constructs encoding Oct4 and either Sox2 or Klf4, without the
GFP gene (OSK lentiviral vectors) (Figure 1a).
In addition, we decided to improve another limit of our initial
procedure, that is, the purity of the CM population employed.
Even if the percentage of CF contamination was very low
with the culture methods used, we could not assume that the
clones derived from CM cultures were all generated from
CMs. Thus, in order to eliminate the chances of generating
iPS cells from contaminating CFs, we adopted a method
previously employed for monitoring the differentiation of
mouse ES (mES) cells into CMs:
11 4 days before transduction
with OSK lentiviral vectors, primary cultures were incubated
with a cardiac-speciﬁc vector in which GFP expression is
driven by a short fragment of the cardiac troponin-I (TNNI3)
proximal promoter linked to a cardiac a-actin enhancer
(TNNI–GFP lentivirus vector). The brightest GFP-positive
cells were sorted and plated directly onto gelatin-coated
dishes, ready for incubation with OSK lentiviral vectors
(Supplementary Figure 2).
FACSanalysisrevealedthatE60%ofcellsoriginatingfrom
CM cultures and only E0.9% of cells originating from
CF cultures expressed GFP after transduction with the
TNNI3–GFP lentivirus vector (Figure 1b, upper left panel;
Supplementary Figure 3 and related Supplementary Movie
S1). All these GFP-positive cells expressed a-sarcomeric
actin (a-SARC), indicating that they were CMs (Figure 1b,
upper right panel). The degree of purity of the sorted brightest
cells was conﬁrmed by FACS and by quantitative Real Time
PCR (qRT-PCR) analyses of CM- and CF-speciﬁc markers
(Figures 1b, lower panels, and 1c).
Moreover, to exclude the possibility that progenitor cells or
immatureCMswerecontributingtoanyreprogrammingtaking
place, we tested for the expression of antigens and genes
that characterize developing cardiac cells. A contribution by
putative cardiac progenitors was ruled out by the absence of
c-kit-, isl1-, and Sca1-positivity in cells selected for TNNI3-
driven GFP expression (Figure 1d). In addition, the expres-
sionofT-boxtranscriptionfactor5(TBX5),beta-myosinheavy
chain (b-MHC), and NKX2.5 – genes expressed in immature
CMs – was either greatly reduced or zero in cells after the
sorting step (Figure 1e). In contrast, genes considered late,
such as alpha-myosin heavy chain (a-MHC) and TNNI, were
highly expressed after selection. As expected, GATA4 was
always expressed, and mES cells never expressed CM-
related genes.
We then used OSK lentiviral vectors to induce reprogram-
ming of cardiac cells. Compared with transduction with OSKM
constructs,reprogrammingwassigniﬁcantlyincreasedinboth
compartments with the use of only OSK. Indeed, we counted
thenumberofcolonies/plateexpressingalkalinephosphatase
(ALP) – a hydrolase typical of the undifferentiated mES cell
state – 18 days after incubation with OSK lentiviral vectors
and found that the CM compartment became signiﬁcantly
more prone to reprogramming than the CF one (Figure 2a;
Supplementary Figure 4). Moreover, 5-bromo-20-deoxyuri-
dine incorporation experiments conducted on GFP-expres-
sing CMs revealed that DNA synthesis increased after
transduction with OSK (Figure 2b). These results strongly
suggest that neonatal CMs transduced with the three
transcription genes proliferate while de-differentiating. Visual
conﬁrmation attested that the clones from the CM compart-
ment spread much faster and become bigger than those
generated from CFs. With increased number of culture
passages, the morphology of CM- and CF-derived iPS cells
increasingly resembled that of ES cells (Figure 2c).
Molecular characterization of CM- and CF-derived iPS
cells. Immunoﬂuorescence, colorimetric assay of ALP, and
molecular analyses were conducted at different time points
after OSK transduction. Twelve days after incubation with
OSK lentiviral vectors, we found that cells of CM- and
CF-derived colonies expressed stage-speciﬁc embryonic
antigen 1 (SSEA-1), an embryonic surface marker
(Figure 2d). In addition, cells were positive for ALP, and
endogenous octamer-binding transcription factor 4 (Oct4)
was found reactivated. These results further proved that
reprogramming was taking place.
Teratoma formation. We conﬁrmed the pluripotency
of newly formed CM-derived iPS cells by the ability to form
teratomas when injected subcutaneously in NOD-scid mice.
Tumors were found in all these mice after 4 weeks.
Hematoxylin/eosin staining demonstrated the presence of
the three germ cell layers (Figure 2e). Moreover, the
karyotype did not present abnormalities and chromosome
conformation was considered normal (Figure 2f).
Generation of chimeras. We next investigated whether
CM-derived iPS cells were of a sufﬁcient quality to produce
adult chimeras. Injection of CM-derived iPS cells generated
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Cell Death and DifferentiationFigure 1 CM- and CF-derived iPS cells obtained through transduction with OSK factors. (a) Maps of the two bicistronic OSK constructs used to improve the efﬁciency of clone
generation in CMs. LTR, long terminal repeats; Tk, thymidine kinase; SFFV, spleen focus-forming virus promoter; TaV, Thosea asigna virus 2A-like sequence; FMDV, foot-and-
mouth disease virus 2A-like sequence. (b) FACS analysis showing the percentage of GFP-positive cells in cultures of CFs and CMs after incubation with the TNNI3–GFP lentivirus
vector (upper left panel); scatter plot of a-SARC-expressing GFP-positive cells from a CM culture (upper right panel); FACS analysis on the brightest sorted CMs demonstrating the
purity of the population (lower right and left panels). a-SARC, alpha-sarcomeric actin; 1B10, ﬁbroblast surface protein marker; PE, phycoerythrin; APC, allophycocyanin.
(c) Enrichment of the CM population demonstrated by qRT-PCR. CMs do not express the ﬁbroblast marker prolyl 4-hydroxylase (P4Hb). An axis break has been introduced to
remove uninformative areas. CFM, starting cardiac population containing CMs and non-CMs; CM, sorted CM population. (d) Scatter plots of c-kit, Isl1, and Sca1 expression in
cardiac cells obtained from hearts atdays 12.5 and 17.5 of gestation,1 day after birth, and after TNNI-sorting. (e)qRT-PCRanalysisofcontrolmEScellsandcardiaccellsobtained
from hearts at days 12.5 and 17.5 of gestation, 1 day after birth, and after TNNI sorting
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Cell Death and Differentiationfrom CD1 mice (white furred) into blastocysts of C57BL/6
mice (black furred) gave rise to newborn chimeras that
developed into adulthood and that showed coat-color
chimerism, indicating differentiation of iPS cells into
functional melanocytes (Figure 2g).
Expression of OSK factors and cardiac genes. qRT-PCR
was conducted to determine the temporal dynamics of gene
expression during de-differentiation in CMs transduced with
OSK. Suppression of the exogenous human embryonic
genes (Oct4, Sox2, and Klf4) and endogenous mouse
cardiac genes (TNNI, a-MHC) occurred at around day 30
post-transduction and was concurrent to re-expression of
endogenous mouse embryonic genes (Oct4, Nanog)
(Figure 2h). The cells had therefore been reprogrammed at
around this time and had reached a state of multipotency.
An increase in transcription of exogenous Oct4 and a
modest expression of a-MHC was noticed at day 18 of
reprogramming.Accordingtoarecentstudy,duringtheperiod
of de-differentiation there can be temporary expression of
exogenous Oct4, which inhibits the transcription of Sox2,
permitting subsequent mild activation of differentiation mar-
kers.
12 However, as long as the expression of exogenous
Oct4 is transient, the reprogramming process progresses.
Global gene expression. Pearson’s correlation of the
global gene expression proﬁles obtained with DNA
microarrays revealed that CM- and CF-derived iPS cells
are clustered closely with mES cells (Figure 3a). Samples
obtained from each stem cell type always had an
inter-sample correlation of more than 0.90 (Supplementary
Figure 5).
When the threshold was set at a twofold change, 319 genes
resulted differentially expressed in CM-derived iPS cells
versus mES cells, whereas 381 genes were differentially
expressed in CF-derived iPS cells versus mES cells. Out of
these differences, only 172 overlapped in the two iPS cell
compartments (Figure 3b). These differences were reduced
to 87 genes when the threshold was set at a ﬁvefold change
(Figure 3c). At this threshold, genes that were differently
upregulated in both iPS cell types versus mES cells included
actin-binding protein MIPP and Brachyury. Other genes were
upregulated more in CM-derived iPS cells than in CF-derived
iPS cells, such as insulin-like growth factor binding protein 5
(Igfbp5), C1q tumor necrosis factor related protein
2 (C1QTNF2), and aldehyde dehydrogenase family 3,
subfamily A1 (Aldh3a1).
Gene ontology (GO) annotation of the iPS cell-source-
dependent differentially expressed genes (DEG) list. We
hypothesized that some of the iPS cell-source-dependent
DEGs would be involved in molecular pathways important for
differentiation in CMs. In order to identify which types of
global cellular processes or speciﬁc molecular functions were
responsible for the propensity of CM-derived iPS cells to
become CMs, the DEG list was ﬁrst annotated using the GO
database. Out of the genes found differentially expressed
with the twofold-change threshold, 463 genes were assigned
to biological process, cellular component, and molecular
function categories. The highest percentages of genes in the
biological process domain regarded cellular process,
biological regulation, and regulation of biological process
(Figure 3d, upper pie chart); in the molecular function
domain, the highest numbers of genes were part of
binding, catalytic activity, and molecular transducer activity
(Figure 3d, middle pie chart); in the cellular component
domain, cell, cell part, and organelle had the most hits
(Figure 3d, lower pie chart). These data conﬁrm that CM- and
CF-derived iPS cells are similar, but not identical, to each
other and to mES cells.
Expression proﬁle of genes involved in cardiovascular
and stemness pathways. The genes found signiﬁcantly
differentially expressed were then grouped in relationship to
various pathways involved in cardiac development and
stemness using the GeneSifter software (PerkinElmer,
Seattle, WA, USA); results were classiﬁed according to the
terminology given by this software (Supplementary Figure 6).
For the smooth muscle cell (SMC) differentiation pathway,
we found that although there were no signiﬁcant differences
among the three stem cell types, CM-derived iPS cells
tended to cluster with CF-derived iPS cells; in contrast,
CM-derived iPS cells clustered with mES cells for
genes related to endothelial cell (EC) differentiation
(Figure 4, upper-left panels). The genes that we found
signiﬁcantly upregulated in CM-derived iPS cells were
wingless-related MMTV integration site 7 (Wnt7a),
transcriptional co-activator with PDZ-binding motif (TAZ),
and low-density lipoprotein receptor-related protein 6 (Lrp6),
which was signiﬁcantly upregulated in CF-derived iPS cells as
well (Figure 4, histograms).
Cardiogenic potential of CM- and CF-derived iPS cells
in vitro. Once the de-differentiation process was proven to
take place, we sought to determine whether it was possible to
differentiate CM- and CF-derived iPS cells into CMs. To this
end, we studied mouse embryonic ﬁbroblast (MEF)-derived
iPS cells along with mES cells and CM- and CF-derived iPS
cells, and exposed EBs grown from these cells to bone
morphogenetic protein 2 (BMP2), according to published
procedures.
13 After 3 days, EBs were collected and stained
for Flk-1, an embryonic-stage cardiomyogenic-lineage
precursor marker.
14 We found that Flk-1 positivity was
present at this time in several clones originating from
CM- (Figure 5a, left panel) or CF-derived iPS cells exposed
to BMP2. FACS analysis performed at early time points of
differentiation showed that CM-derived iPS cells started to
express Flk-1 before the other cell types tested (Figure 5b).
Positivity for c-kit, which is expressed in putative cardiac
progenitor cells,
15 was not encountered (Figure 5a, right
panel).
Western blotting was then carriedout forcardiac markersto
obtainproofofCMdifferentiationfromiPScells.Wefoundthat
a-SARC, TNNI, myosin light chain 2V (MLC 2V), and NKX2.5
were expressed in cells upon exposure to BMP2 (Figure 5c).
MLC 2A – the atrial MLC isoform – was not expressed,
indicating that cells were more frequently differentiating
toward the ventricular lineage.
Beating areas started to appear 6 days after BMP2
exposure (Supplementary Movies S2 and S3). The number
iPS cell generation from cardiomyocytes
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Cell Death and Differentiationof these beating areas was greater in cultures originating from
CM-derived iPS cells (Figure 5d). The greater propensity of
CM-derived iPS cells to become CMs compared with CF- and
MEF-derived iPS cells and mES cells was established
by qRT-PCR analysis conducted at different time points.
The appearance of early CM markers, such as Brachyury,
Mef2c, and Tbx5 (Figure 5e, upper panels), became evident
earlier in CM-derived iPS cells than the other cell types. The
expression of mature myocardial genes, such as a-MHC and
TNNI,washigher inCM-derivediPScellsatthelaterstagesof
differentiation (Figure 5e, lower panels).
In addition, both cardiac-derived iPS lines could differenti-
ate into three lineages found in the myocardium: CMs, ECs,
and SMCs (Figure 6a). However, CM-derived iPS cells
differentiated into CMs more often than into SMCs or ECs.
In fact, the number of cells expressing a-MHC and a-SARC
was signiﬁcantly greater in those originating from CM-derived
iPS cells (Figure 6b).
Ca
2þ response in CM- and CF-derived iPS cells after
BMP2 exposure. Functional differences in commitment
toward the cardiac phenotype was tested by comparing
stimulus-induced Ca
2þ release in differentiated CM- and
CF-derived iPS cells and neonatal CMs, used as a reference
(Figure 7). Responsiveness to caffeine,
16 which acts on
muscle-speciﬁc ryanodine receptor channels, was
signiﬁcantly higher in differentiated CM-derived iPS cells
than in differentiated CF-derived iPS cells. Responsiveness
to nicotine, acting on the nicotinic acetylcholine receptor
(nAChR), was negligible in all cell types, and this ruled out
differentiation toward skeletal muscle. Responsiveness to
ATP and acetylcholine (ACh), mediated by inositol
trisphosphate (IP3) release in many cell types and well
represented in SMCs,
17 was low in all cell types. The
combined unresponsiveness to nicotine and infrequent
response to IP3-mediated stimuli suggests that caffeine
responsiveness was largely indicative of cardiac
differentiation.
Discussion
In this report, we demonstrate that two myocardial cell types
can be reprogrammed to generate iPS cells and that both can
produce new cardiovascular cell populations in vitro, albeit
with different efﬁciencies. In particular, we show for the ﬁrst
time that CMs are capable of generating iPS cells, and that
when we used only OSK for the reprogramming of cardiac
cells, the CM compartment, remarkably, was signiﬁcantly
more efﬁcient in generating iPS cells than was the CF one. As
post-natal CMs lose their proliferative capacity soon after
birth, they possess a limited ability to survive and undergo cell
replication in culture. In fact, CMs have a proliferation index
that peaks at B10% on neonatal day 4.6 and declines rapidly
to zero thereafter,
18 and can only be forced to re-enter the cell
cycle by transfecting cell-cycle regulatory genes or by
exposure to growth factors.
19 Therefore, it is conceivable that
CM-derivediPScellswereformedfromtheresidualnumberof
CMsstill actively cycling immediatelyafter birth. Why CMsare
better at producing iPS cells than CFs with the OSK protocol
needs further investigation.
In addition, we show that CM-derived iPS cells are better at
differentiating into functional CMs after exposure to BMP2
than are CF-derived iPS cells or mES cells, or MEF-derived
iPS cells. In fact, CM-derived iPS cells generated more
a-MHC- anda-SARC-positive cellsand beatingareas per dish
after the cardiac differentiation procedure than did the other
stemcelltypes.BMP2,atransforminggrowthfactorb(TGF-b)
family member that is expressed in lateral endoderm and
ectoderm, has an important role in cardiac development in
vertebrate embryos.
20 Expression of cardiac-speciﬁc proteins
by TGF-b is mediated by GATA4 and NKX2.5,
21 and this
factor was found to be upregulated more than threefold
in CM-derived iPS cells compared with mES cells and
CF-derived iPS cells when the threshold was set at a twofold
change.
We also found that although CM- and CF-derived iPS cells
are comparableto mES cellsin the expression of transcription
factors (e.g., endogenous Oct4) and surface markers for
pluripotency (e.g., SSEA-1), they did show architecture-
speciﬁc variations in their gene expression proﬁles, which
may probably explain the differences in the yield of CMs
following the induction of cardiogenic differentiation. Indeed,
microarray analysis of global gene expression in iPS cells
derived from both cardiac compartments identiﬁed upregula-
tion of genes directly involved in cardiogenesis during the
early days of embryonic life, such as Brachyury and ﬁbroblast
growth factor 2 (Fgf2). Brachyury facilitates BMP-induced
differentiation of human and mouse pluripotent stem cells,
and cooperates with Fgf2 (via ERK) in mesoderm rather than
endoderm.
22
Igfbp5, C1QTNF2, and Aldh3a1 were also found upregu-
lated in iPS cells when the threshold was set at a twofold
change. Igfbp5, found in the precardiac region and early
cardiac crescent,
23 encodes a member of the IGF-I-binding
proteinfamilythatbindswithhighafﬁnitytobothIGF-IandIGF-
II.
24 Igfbp5 expression is induced by treatment with IGF-I in
Figure 2 Characterization of CM-and CF-derived iPScolonies. (a) Numberof iPScolonies/35mm-dish formedon MEFsafter 15 daysfromtransductionof CMsand CFs
with OSK reprogramming factors. *Po0.005: t-test (N¼5 experiments for each clone). (b) Proliferation of post-natal CMs before and after transduction with OSK factors
(leftpanel).BrdUlabelinginacolony15daysaftersorting(rightpanel).Scalebarrepresents200mm.*Po0.005:t-test(N¼5experimentsforeachclone).(c)Morphologyof
CM-and CF-derived cells after 15 days from reprogramming (upper and lower left panels). Morphology of CM- and CF-derived iPS colonies at passages2 and 20 (upper and
lower right panels). Scale bars represent 200mm. (d) Example of a 12-day-old CM-derived iPS clone stained for SSEA-1 (upper left panel); ALP expression in neonatal
CM-derivediPScells15daysaftertransductionwithOSKvectors(upperrightpanel);Oct4andDAPIstaining(lowerrightandleftpanels,respectively)inacolonyformedfrom
CMs. Scale bars represent 200mm. (e) Teratoma formation 4 weeks after injection of CM-derived iPS cells in NOD-scid mice. Hematoxylin/eosin-stained sections
demonstrating the presence of all three germ layers. (f) Normal karyotype of neonatal CM-derived iPS cells. (g) Two-week-old chimeric mouse, derived from a C57BL/6
blastocyst injected with CM-derived iPS cells obtained from a white CD-1 mouse, between two C57BL/6 wild-type littermates. CM-derived iPS cells are responsible for the
agouti coat color. (h) qRT-PCR analysis of embryonic- and cardiac-marker genes in mES cells and CMs transduced with OSK factors (N¼5 experiments for each clone)
iPS cell generation from cardiomyocytes
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Cell Death and Differentiationboth aortic and vascular SMCs in a wortmannin- and
rapamycin-sensitive manner, suggesting that induction of
Igfbp5 is downstream of the PI3K/mTOR signaling pathway.
25
Higher expression of Igfbp5 may indicate different epigenetic
imprinting in CM- and CF-derived iPS cells. Regarding
C1QTNF2, it was reported that this protein induces the
Figure 3 Genesifteranalysisof changesin geneexpressionin mEScellsand CM-andCF-derived iPScells.(a)Comparisonsof globalgeneexpressionin mEScellsand
CM-derivediPScells(leftpanel),mEScellsandCF-derivediPScells(middlepanel),andCM-andCF-derivediPScells(rightpanel).(b)Venndiagramofthenumberofgenes
differentially expressed in CM- and CF-derived iPS cells and mES cells when a twofold change was taken as the threshold value. 381 genes were differently expressed
between mES and CF-derived iPS cells, whereas 319 genes were differently expressed between mES and CM-derived iPS cells; 172 of these genes were differently
expressed in both data sets (N¼3 experiments for each clone). (c) GeneSifter program heat map analysis of Illumina mouse gene array data from mES cells and CM- and
CF-derived iPS cells: 87 genes were found to be signiﬁcantly differentially expressed in CM- and CF-derived iPS cells compared with mES cells when a ﬁvefold change was
takenasthethresholdvalue(N¼3experimentsforeachclone).(d)GOannotationsofgenesfounddifferentiallyexpressedatthetwofold-changethreshold.Thedomainsare
biological process (upper chart), cellular component (middle chart), and molecular function (lower chart) (N¼3 experiments for each clone)
iPS cell generation from cardiomyocytes
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Cell Death and Differentiationphosphorylation of AMPK in myocytes, resulting in increased
glycogenaccumulation andfattyacidoxidation.
26Ontheother
hand, Aldh3a1 expression regulates proliferation, survival, as
well as cellular response to oxidative stress.
27 It is thus
possible that this gene is implicated in CM differentiation.
Wnt7aisahighlyupregulatedgeneinCM-derivediPScells.
Wnt7a mRNA expression is present in the ventricles of
embryos,
28 and Wnt and Wnt-related signal transduction
contributes to mesodermal speciﬁcation during early cardio-
genesis and later cardiac development and maturation.
29 It is
well known that the formation of mesoderm is dependent on
canonical Wnt signaling.
30 In particular, Wnt/b-catenin signal-
ing uses Brachyury expression as a marker of activation.
31
Thus, the upregulation of Wnt and Brachyury in CM-derived
iPS cellsmimics the mechanism occurring in the earlyembryo
for mesoderm induction, a prerequisite for the formation of
cardiac progenitor cells.
32
Another gene found highly upregulated in CM-derived iPS
cells with respect to mES cells is Lrp6. This gene regulates
speciﬁcation, proliferation, and survival of cardiac progenitors
and the expression of multiple cardiogenic genes, including
Tcfap2a and Pax3, Isl1, Msx1/Msx2, Fgf8, and Mef2C during
cardiogenesis.
33
The ﬁnal gene found signiﬁcantly upregulated in
CM-derived iPS cells is TAZ, which encodes for a WW
domain-containing cofactor. TAZ co-associates with TBX5
and histone acetyltransferase proteins and mediates TBX5-
dependent gene activation during cardiac development.
34
Figure 4 Cardiovascular and stemness pathways in CM- and CF-derived iPS cells. Heat maps (upper-left panels) and histograms of the genes found to be signiﬁcantly
up- or downregulated in different cardiovascular- and stem-cell-related pathways. The classiﬁcation shown is that generated by GeneSifter. *Po0.05 versus mES, ANOVA
(±S.E.M.). Gene expression by DNA microarray, analysis by GeneSifter software (N¼3 experiments for each clone)
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Cell Death and DifferentiationFigure 5 Cardiac lineage differentiation of CM- and CF-derived iPS cells in vitro. (a) Immunoﬂuorescence for Flk-1 on an EB 4 days after exposure to BMP2, attesting
in vitro differentiation into CM precursors (left panel). The lack of a signal for c-kit demonstrates the absence of putative cardiac progenitor cells that might have been
responsible for the cardiogenic differentiation observed (right panel). Scale bars represent 100mm. (b) Flow cytometry plots for Flk-1 expression at 0, 5, and 12h after
exposure to BMP2 in mES and CM- and CF-derived iPS cells. (c) Representative western blot of cardiac markers in differentiated and undifferentiated CF- and CM-derived
iPS cells. Ventricular and atrial cells were used as positive controls. To remove uninformative areas, the panel has been cropped. (d) Number of beating areas in cultures
derived from mES cells, CM- and CF-derived iPS cells, and MEF-iPS cells, 6, 7, and 8 days after exposure to BMP2. *Po0.001: t-test (N¼4 experiments for each clone).
(e) qRT-PCR analysis of early and late cardiac marker genes in mES cells and CM-, CF-, and MEF-derived iPS cells at different time points after transduction of cells with
OSK transcription factors. An axis break has been introduced to remove uninformative areas (N¼5 experiments for each clone)
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Cell Death and DifferentiationTAZ also functions as a co-activator of GATA4, stimulating
GATA4 activity on the ANF promoter in several cell lines.
TAZ and GATA4 physically interact with each other thorough
theN-terminalregionofTAZandactivationdomainofGATA4.
Moreover, the Notch signaling pathway may regulate the
activity of cardiac transcription factors, including GATA family
proteins, by inhibiting TAZ.
34
All these differences between CM-derived iPS cells
and the other stem cell types investigated in our
study strongly suggest that CM-derived iPS cells retain
an ‘epigenetic memory’ of the cardiogenic fate of their
originating cell type, which can inﬂuence the outcome of
subsequent differentiation. On this point, it has been demon-
strated that iPS cells derived from human ﬁbroblasts, adipose
tissue, and keratinocytes, and from granulocytes, muscle
progenitors, ﬁbroblasts, and lymphocytes
35 show differences
in gene expression that are indicative of transcriptional
memory. The DNA methylation pattern of iPS clones has also
been used to predict the somatic cell from which they were
derived.
36
We have demonstrated as a proof of principle that CMs can
generate iPS cells. We believe that these cells have
signiﬁcant investigative potential in the study of epigenetic
mechanisms and the genes underlying cell cycling and
cardiomyogenic differentiation processes.
Materials and Methods
Generation of lentiviral vectors. The lentiviral vector used to introduce a
GFP transgene under the inﬂuence of a cardiac-speciﬁc promoter for the
ultrapuriﬁcation of CMs (TNNI3–GFP lentivirus vector), was produced as described
elsewhere.
11 See Supplemental Experimental Procedures.
The lentiviral vectors employed for the induction of reprogramming via OSK
factors harbored bicistronic constructs expressing Oct4 and either Sox2 or Klf4
(OSK lentiviral vectors). These vectors, and those used for transducing all 4
Yamanaka factors (OSKM), were generated as described in Supplemental
Experimental Procedures and Supplementary Table 1.
Myocardial cell cultures. CMs and CFs were obtained from of 1-day-old
CD-1 mice (Charles River Laboratories, Wilmington, MA, USA) as previously
described.
37 All animal procedures were performed in accordance with the Guide for
theCareandUseofLaboratoryAnimalsandapprovedbytheInstitutionalAnimalCare
andUseCommittee.CMswereseededandkeptovernightinmediumcontainingBrdU
to inhibit cell proliferation. See Supplemental Experimental Procedures.
Enrichment of the cardiomyocyte compartment. CMs and CFs were
incubated with the TNNI3–GFP lentiviral vector 3 days after isolation. CMs were
puriﬁed through cell sorting for GFP positivity 48h after transduction. Sorted cells
were plated on gelatin and cultured in CM expansion medium, ready for the
reprogramming step.
Generation of iPS cells. To induce reprogramming, CMs and CFs were
exposed 3 days after sorting to a mixture of equal volumes of the two OSK lentiviral
vectors. Four days after transduction, cells were trypsinized and plated on a mouse
MEF-feeder layer (Millipore, Billerica,MA, USA) at a densityof 1.6 10
3 cells/cm
2
and cultured in propagation medium composed of Knockout DMEM (Invitrogen,
Carlsbad, CA, USA) containing 15% KnockOut Serum Replacement (Invitrogen),
2mM L-glutamine, 100mM NEAA (non-essential amino acids), 10ng/ml bFGF
(Peprotech, Rocky Hill, NJ, USA), 500mM VPA (EMD Biosciences, San Diego, CA,
USA), 100mM b-mercaptoethanol (Invitrogen), 1000U/ml LIF (Millipore), penicillin
(100U/ml), and streptomycin (100mg/ml). Any iPS cells thus derived were
maintained on MEFs in complete medium containing bFGF, VPA, and LIF
(Supplementary Table 2).
Embryoid body formation and in vitro differentiation of iPS
cells. Undifferentiated CM- and CF-derived iPS cells were cultured in
propagation medium containing 2.5ng/ml. BMP2 (Invitrogen) for 12h. Cells were
then harvested by trypsinization, spun down for 5min at 1000r.p.m., and
resuspended in differentiation medium (DF medium) composed of DMEM, FBS,
L-glutamine, NEAA, penicillin, and streptomycin. Successively, iPS cells were
counted and diluted down to 25000 cells/ml. The underside of bacterial dish lids
was then spotted with 60 drops containing 500 cells each. After 4 days of hanging-
drop culture, EBs were collected, seeded on gelatinized plates, and cultured in
DF medium.EBsbeganto showareasof spontaneouscontractionon day6. Onthe
forth day, some EBs were collected, ﬁxed in 4% paraformaldehyde, and stained for
Flk-1; 10 days after BMP2 treatment, cells were ﬁxed and stained for a-SARC in
order to identify any cells differentiated into CMs.
Chimera formation. iPS Cells deriving from CMs or CFs were aggregated
with zona-pellucida-free eight-cell stage embryos to generate chimeras as
described previously.
38
Teratoma. formation. 5 10
5 cells/mouse were injected subcutaneously in
ﬁve NOD-scid mice. Tumors were sought after 4 weeks.
Gene expression proﬁling. Expression of endogenous and exogenous
genes was analyzed by RT-PCR (OSKM) and qRT-PCR (OSK) using standard
protocols (Supplementary Tables 3 and 4). See Supplemental Experimental
Procedures.
DNA microarray for whole-genome gene expression. BeadChip
Array MouseWG-6 v2 (Illumina, San Diego, CA, USA) was used for whole-genome
expression analysis following the protocol provided by Illumina. See Supplemental
Experimental Procedures.
Western blotting analyses, immunohistochemistry and
immunocytochemistry, and ﬂow cytometry and cell
sorting. These procedures were performed following standard protocols. See
Supplemental Experimental Procedures.
Ca
2þ response in CM- and CF-derived iPS cells after BMP2
exposure. FourdaysafterBMP2treatment,EBswereplatedonglasscoverslips
and incubated in DF medium. During the incubation period, cells migrated from the
EBs, forming an almost uniform cell layer. Freshly dissociated neonatal CMs were
similarly plated and kept for 1 day in CM medium.
Atday7,cellswereloadedwiththeCa
2þ-sensitivedyeFluo4-AM(20mM,1hat
371C). Images (512 512 pixels) were recorded (ﬁeld size 441 441mm) with a
confocal microscope (Leica TCS-SP2, Leica, Wetzlar, Germany) at a sampling rate
of 1.2Hz. The ratio between dye ﬂuorescence over time and its value in basal
conditions (F/F0) was recorded. As cell boundaries were not visible in cell layers,
response to the test intervention was quantiﬁed by the proportion of pixels
corresponding to cell-covered areas (‘cell pixels’) in which F/F0 changed more than
athresholdvalue(‘activepixels’,Figure7,rightpanels).Thenumber‘cellpixels’was
counted in digital images (Figure 7, left panels), obtained by applying a F/F0
threshold to pixel values integrated over the recording period.
Cells were superfused with Ca
2þ-free (0mM Ca
2þ þ 1mM EGTA) Tyrode’s
solution. Substances (10mM caffeine, 200mM ATP, 30mM ACh, or 100mM
nicotine), diluted in the superfusate, were applied by a fast switch perfusionsystem.
Experiments were performed at 25±21C.
Statistics. All data are expressed as mean±S.E.M.. For cell studies, we
analyzed a total of four different clones per cell type. In some instances, data were
pooled from different cultures originating from each clone. Unpaired t-test or one-
way ANOVA was used, as appropriate, to assess statistical signiﬁcance between
groups. A binomial distribution of values was assumed whenever ANOVA was
applied to categorical data (SPSS 19); Bonferroni correction was applied to
post-hoc comparisons. As the experimental unit is the cell and each cell is
representedbymultiplepixels,consideringpixelnumberswouldundulyincreasethe
analysis degrees of freedom; thus, to avoid overestimating signiﬁcance, pixels were
binned by using a bin size approaching cell size (200 pixels E150mm). Pearson’s
correlation was used to test the internal correlation between the samples and
between the groups involved in gene expression assay. No signiﬁcant differences
were found in the data obtained from each clone of a speciﬁc cell type.
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